Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Royer

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|August 28, 2025
Trifluridine- and tipiracil-induced DPD inhibition mimicking DPD deficiency: a case reportAntonin Schmitt, Baptiste Bouillet, Bernard Royer, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of carboplatin]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of everolimus]Françoise Goirand, Bernard Royer, Anne Hulin, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Bernard Royer, Etienne Chatelut, et al.
Therapie|July 10, 2016
[Not Available]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Françoise Goirand, Bernard Royer, Anne Hulin, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of cisplatin]Anne Hulin, Bernard Royer, Etienne Chatelut, et al.
Molecules (Basel, Switzerland)|January 12, 2021
Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical PracticeJennifer Lagoutte-Renosi, Bernard Royer, Vahideh Rabani, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|August 28, 2025
Trifluridine- and tipiracil-induced DPD inhibition mimicking DPD deficiency: a case reportAntonin Schmitt, Baptiste Bouillet, Bernard Royer, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of carboplatin]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of everolimus]Françoise Goirand, Bernard Royer, Anne Hulin, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Bernard Royer, Etienne Chatelut, et al.
Therapie|July 10, 2016
[Not Available]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Françoise Goirand, Bernard Royer, Anne Hulin, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of cisplatin]Anne Hulin, Bernard Royer, Etienne Chatelut, et al.
Molecules (Basel, Switzerland)|January 12, 2021
Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical PracticeJennifer Lagoutte-Renosi, Bernard Royer, Vahideh Rabani, et al.
Pageof 7